There should be something to look forward to, else why run the OLE?
More than statistical interpretation, would be interested to see what the prolonged duration of the OLE can do, compared to the initial trial of 14 weeks. More participants are getting the drug. Should give a better understanding of responses (both favorable and adverse).
Let us hope that it helps going ahead(next steps).